Issue 1, 2015

Dual secured nano-melittin for the safe and effective eradication of cancer cells

Abstract

The clinical application of natural and synthetic amphipathic peptides (e.g., melittin) for cancer therapy is hindered by their notorious side effect, lysing red blood cells. To safely deliver a therapeutic peptide to the tumor tissue and kill cancer cells, we developed an environment-sensitive peptide delivery system, dual secured nano-sting (DSNS), through the combination of a zwitterionic glycol chitosan and disulfide bonds. Melittin loaded DSNS could kill almost 100% of MCF-7, HCT-116, SKOV-3, and NCI/ADR-RES (multidrug resistant) cancer cells at the concentration of 5 μM, while not showing any hemolytic effect.

Graphical abstract: Dual secured nano-melittin for the safe and effective eradication of cancer cells

Supplementary files

Article information

Article type
Communication
Submitted
22 Aug 2014
Accepted
28 Oct 2014
First published
28 Oct 2014

J. Mater. Chem. B, 2015,3, 25-29

Author version available

Dual secured nano-melittin for the safe and effective eradication of cancer cells

B. Cheng, B. Thapa, R. K. C. and P. Xu, J. Mater. Chem. B, 2015, 3, 25 DOI: 10.1039/C4TB01401D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements